- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06484621
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
Using Acceptance and Commitment Therapy to Promote Autonomous Motivation for Increased Physical Activity and Improved Weight Loss Maintenance in Bariatric Surgery Patients: A Randomized Trial
The goal of this clinical trial is to learn if a psychological intervention can increase regular physical activity to help prevent weight regain after metabolic bariatric surgery in adults. The main questions it aims to answer are:
- Does the psychological intervention increase physical activity?
- Does the psychological intervention prevent weight regain?
- Does the psychological intervention increase internal motivation for physical activity and acceptance of the discomfort that can come with physical activity?
Researchers will compare the psychological intervention to an educational intervention to see if the psychological intervention works to increase physical activity and prevent weight regain after metabolic bariatric surgery.
Participants will:
- Complete 12 months of either the psychological or educational intervention. This includes attending online workshops with a small group of participants, completing brief homework assignments, and having individual telephone calls with a counselor.
- Wear a device to measure physical activity, use an electronic scale to measure body weight, and complete questionnaires at home on five separate occasions over an 18-month period
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chloe David, B.S.
- Phone Number: 860-972-5750
- Email: Chloe.David@hhchealth.org
Study Locations
-
-
Connecticut
-
Hartford, Connecticut, United States, 06102
- Recruiting
- Hartford Healthcare
-
Contact:
- Clinical research coordinator
-
Principal Investigator:
- Dale S Bond, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Having undergone either a primary Roux-en-Y gastric bypass or sleeve gastrectomy bariatric procedure between 6 and 20 months prior to enrollment
- Have reached their nadir weight and regained less than 10% of maximum weight lost based on weight measurements
- Had their surgery performed at Hartford Hospital or another surgical weight loss center within the Hartford HealthCare system.
- Able to provide consent
- Willing to engage in and complete the study protocol
- Able to safely participate in a physical activity program
Exclusion Criteria:
- Have regained 10% or more of maximum weight lost based on weight measurements
- Cannot ambulate independently
- Do not speak/read English at a 6th grade level
- Are pregnant, lactating, less than 6-months postpartum or plan to become pregnant during the course of the study
- Report current involvement in a weight management program outside of standard care
- Begin taking a newly prescribed medication for weight loss less than two months prior to study enrollment
- Begin taking a newly prescribed medication or change the dosage/frequency of pre-existing medications that are associated with weight loss/weight gain but not taken to produce weight loss less than two months prior to study enrollment
- Report any conditions or plans that would preclude adherence to the study protocol (i.e., plans to relocate, psychiatric problems such as substance use disorder, or terminal illness)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acceptance and Commitment Therapy-Based Physical Activity Intervention
Provides experiential training in values-clarification and acceptance strategies to increase autonomous motivation for achieving self-determined physical activity goal via group-based workshops, email feedback, and brief support calls.
|
Provides experiential training in values-clarification and acceptance strategies to increase autonomous motivation for achieving self-determined physical activity goal via group-based workshops, email feedback, and brief support calls.
Other Names:
|
|
Active Comparator: Physical Activity Education Intervention
Provides didactic instruction on physical activity and behavioral strategies for achieving prescribed physical activity goals via group-based workshops, email feedback, and brief support calls.
|
Provides didactic instruction on physical activity and behavioral strategies for achieving prescribed physical activity goals via group-based workshops, email feedback, and brief support calls.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Moderate-to-Vigorous Physical Activity
Time Frame: From baseline to the end of treatment (at 12-months) and follow-up (at 18-months)
|
Change in daily minutes of MVPA: total (in >=1-minute bouts) and bouted (in >=10-min bouts)
|
From baseline to the end of treatment (at 12-months) and follow-up (at 18-months)
|
|
Amount (%) of weight regain
Time Frame: From baseline to end of treatment (at 12-months) and follow-up (at 18-months)
|
The percentage of weight that is regained from baseline
|
From baseline to end of treatment (at 12-months) and follow-up (at 18-months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Autonomous motivation
Time Frame: From baseline to end of treatment (at 12 months) and follow-up (at 18 months)
|
Relative Autonomy Index Score measured via the Exercise Self-Regulation Questionnaire
|
From baseline to end of treatment (at 12 months) and follow-up (at 18 months)
|
|
Physical Activity Acceptance
Time Frame: From baseline to end of treatment (at 12-months) and follow-up (at 18-months)
|
Total Physical Activity Acceptance Questionnaire Score
|
From baseline to end of treatment (at 12-months) and follow-up (at 18-months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Dale S Bond, PhD, Hartford Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 037604
- 1R01DK135463-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.